Photodynamic antimicrobial chemotherapy in mice with Pseudomonas aeruginosa-infected wounds

Area of Science:

• Photochemistry
• Microbiology
• Biomedical Engineering

Background:

• Pseudomonas aeruginosa is a significant opportunistic pathogen causing various infections.
• Developing novel antimicrobial strategies is crucial to combat antibiotic resistance.
• Photodynamic antimicrobial chemotherapy (PACT) offers a light-activated approach to kill microbes.

Purpose of the Study:

• To evaluate the efficacy of protoporphyrin IX-ethylenediamine derivative (PPIX-ED)-mediated PACT against Pseudomonas aeruginosa.
• To investigate the mechanism of action of PPIX-ED-PACT on bacterial cells.
• To assess the in vivo therapeutic potential of PPIX-ED-PACT in a wound infection model.

Main Methods:

• In vitro antibacterial assays were performed to determine growth inhibition.
• Atomic force microscopy and acridine orange/ethidium bromide staining were used to analyze bacterial membrane and wall integrity.
• An in vivo model of P. aeruginosa-infected wounds was utilized to assess therapeutic effects.

Main Results:

• PPIX-ED-PACT demonstrated potent inhibition of Pseudomonas aeruginosa growth by inducing reactive oxygen species.
• Degradation of bacterial membrane and wall, leading to content leakage, was observed.
• In vivo studies showed a significant reduction in bacterial load and accelerated wound healing (98% by day 14).

Conclusions:

• PPIX-ED-PACT is a promising therapeutic strategy for combating Pseudomonas aeruginosa infections.
• The mechanism involves photoactivated reactive oxygen species generation and direct bacterial structure damage.
• PPIX-ED-PACT shows significant potential for both in vitro and in vivo applications against P. aeruginosa.